What is AllerQuest?
AllerQuest, LLC operates at the intersection of immunology and pharmaceutical manufacturing, focusing on the development of high-precision skin test reagents. The company is best known for its flagship product, PRE-PEN, which serves as a critical diagnostic tool for identifying patients at risk for penicillin allergies. By providing healthcare providers with reliable, FDA-approved testing solutions, AllerQuest addresses a vital gap in patient safety and clinical diagnostics. The company's operational model emphasizes rigorous scientific standards and medical expertise, ensuring that its diagnostic reagents meet the stringent requirements of modern clinical environments. Following the strategic acquisition of its primary product line by ALK-Abelló, AllerQuest has demonstrated its capacity to innovate within the niche diagnostic market while effectively transitioning its assets to global distribution channels.
How much funding has AllerQuest raised?
AllerQuest has raised a total of $399K across 2 funding rounds:
Debt
$150K
Debt
$249K
Debt (2020): $150K with participation from PPP
Debt (2021): $249K led by PPP
Key Investors in AllerQuest
PPP
Public-Private Partnership
What's next for AllerQuest?
With the successful transition of its core diagnostic assets to ALK-Abelló, AllerQuest is positioned to leverage its recent capital influx to explore further advancements in allergy testing technology. The company's strategic roadmap likely involves scaling its research and development capabilities to address broader immunological diagnostic challenges. As the healthcare industry continues to prioritize accurate, point-of-care diagnostic solutions, AllerQuest's expertise in reagent manufacturing provides a robust foundation for future growth. Investors and industry stakeholders will be monitoring how the firm utilizes its current financial standing to pivot toward new diagnostic frontiers or enhance its existing portfolio of allergy-related medical solutions, ensuring sustained relevance in the evolving landscape of precision medicine.
See full AllerQuest company page
